We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Humana (HUM) to Buy Remaining iCare Shares to Expand Medicare
Read MoreHide Full Article
Humana Inc. (HUM - Free Report) recently announced that it will purchase the remaining 50% of iCare, which is a Wisconsin-based healthcare company.
The health insurance giant, which already owns the other half of iCare will buy the residual share from Centers for Independence, Inc. (CFI). Notably, this joint venture dates back to 1994, catering to members in the Wisconsin region via Medicaid and Medicare plans.
However, financial terms of the deal were kept under wraps. The buyout is also subject to certain closing conditions.
iCare serves 44,000 members through Wisconsin’s Medicaid SSI program, BadgerCare program and Medicare D-SNP plans for individuals eligible for both Medicare and Medicaid.
Humana will be able to strengthen its Medicaid business with this transaction. It remains committed to providing quality medical care across Medicare, Medicaid and Commercial product lines in Wisconsin.
With this deal, the company will now be able to provide Medicare D-SNP plans in the state. This buyout will increase Humana’s overall Medicaid membership to more than 730,000 across four states, namely Florida, Illinois, Kentucky and Wisconsin.
As of Sep 30, 2020, Medicaid membership grew 55.7% year over year owing to the transition of the risk for the Kentucky contract from CareSource along with additional enorllment in Florida.
There is a host of initiatives that the company took recently, which helps carving its growth path. Some of the acquisitions made by the company aided it to achieve long-term growth. It also closed the Enclara deal in January, expanding its hospice pharmacy business line.
We expect these initiatives to bode well for the long haul.
Zacks Rank and Price Performance
Shares of this currently Zacks Rank #4 (Sell) company have gained 17% in a year compared with the industry’s growth of 13%.
Other companies in the same space, such as Centene Corp. (CNC - Free Report) , UnitedHealth Group Incorporated (UNH - Free Report) and Anthem Inc. have also rallied 6.2%, 24.8% and 12.4%, respectively, in the same time frame.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Image: Bigstock
Humana (HUM) to Buy Remaining iCare Shares to Expand Medicare
Humana Inc. (HUM - Free Report) recently announced that it will purchase the remaining 50% of iCare, which is a Wisconsin-based healthcare company.
The health insurance giant, which already owns the other half of iCare will buy the residual share from Centers for Independence, Inc. (CFI). Notably, this joint venture dates back to 1994, catering to members in the Wisconsin region via Medicaid and Medicare plans.
However, financial terms of the deal were kept under wraps. The buyout is also subject to certain closing conditions.
iCare serves 44,000 members through Wisconsin’s Medicaid SSI program, BadgerCare program and Medicare D-SNP plans for individuals eligible for both Medicare and Medicaid.
Humana will be able to strengthen its Medicaid business with this transaction. It remains committed to providing quality medical care across Medicare, Medicaid and Commercial product lines in Wisconsin.
With this deal, the company will now be able to provide Medicare D-SNP plans in the state. This buyout will increase Humana’s overall Medicaid membership to more than 730,000 across four states, namely Florida, Illinois, Kentucky and Wisconsin.
As of Sep 30, 2020, Medicaid membership grew 55.7% year over year owing to the transition of the risk for the Kentucky contract from CareSource along with additional enorllment in Florida.
There is a host of initiatives that the company took recently, which helps carving its growth path. Some of the acquisitions made by the company aided it to achieve long-term growth. It also closed the Enclara deal in January, expanding its hospice pharmacy business line.
We expect these initiatives to bode well for the long haul.
Zacks Rank and Price Performance
Shares of this currently Zacks Rank #4 (Sell) company have gained 17% in a year compared with the industry’s growth of 13%.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Other companies in the same space, such as Centene Corp. (CNC - Free Report) , UnitedHealth Group Incorporated (UNH - Free Report) and Anthem Inc. have also rallied 6.2%, 24.8% and 12.4%, respectively, in the same time frame.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>